Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2024 16:05 ET | Source: Fractyl Health, Inc.

Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates

Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
July 23, 2024 03:30 ET | Source: Custom Market Insights

[Latest] Global Epigenetics Diagnostic Market Size/Share Worth USD 41.6 Billion by 2033 at a 14.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Epigenetics Diagnostic Market Size, Trends and Insights By Product Type...
May 24, 2024 19:45 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice

MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
May 13, 2024 16:00 ET | Source: Fractyl Health, Inc.

Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates

Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
April 30, 2024 08:38 ET | Source: Fractyl Health, Inc.

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

Fractyl Health Announces Multiple Presentations at DDW 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
February 20, 2024 08:38 ET | Source: Fractyl Health, Inc.

Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials

Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
August 29, 2023 07:30 ET | Source: Transparency Market Research

Lyophilized Injectable Market Predicted to Reach USD 5 billion by 2031, Registering at a 5% CAGR | Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for lyophilized injectable is anticipated to advance with almost a 5%...
July 18, 2023 09:15 ET | Source: Lindora Clinic

Lindora taps retail and health industry veteran Colleen Lewis as new CEO, announces new metabolic health services

IRVINE, July 18, 2023 (GLOBE NEWSWIRE) -- Lindora Clinic, a leading weight management and metabolic health company, today announced the appointment of Colleen Lewis as its chief executive officer...
March 20, 2023 06:55 ET | Source: Synlogic, Inc.

Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting

CAMBRIDGE, Mass., March 20, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, announced that positive data from the...
March 07, 2023 06:57 ET | Source: Synlogic, Inc.

Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting

– Podium presentation on Phase 2 phenylketonuria (PKU) data – – Poster presentations on Phase 1 homocystinuria (HCU) data and HCU preclinical data – CAMBRIDGE, Mass., March 07, 2023 (GLOBE...